United States Últimas notícias

INVO Fertility (NASDAQ:IVF) reported a 5% increase in total net revenue for fiscal year 2025, supported by steady expansion across its clinic network and a restructured balance sheet that eliminated several complex legacy equity liabilities.

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Vanderbilt Health announced that a Phase 2a clinical trial evaluating the investigational drug ifetroban successfully met its primary endpoint, demonstrating safety and tolerability in patients with high-risk solid tumors.

SpaceX is negotiating to pay razor-thin fees to Wall Street firms handling its IPO, with banks still likely to rake in about $500 million from the record-setting debut. Sridhar Natarajan reports on Bloomberg Television.

US job openings jumped in April to the highest level in almost two years and layoffs fell. Available positions rose to 7.62 million from 6.89 million in March, according to Bureau of Labor Statistics data. Stuart Paul reports on "Bloomberg Open Interest."

Federal Reserve Bank of Cleveland President Beth Hammack said it's reasonable to keep rates steady for now due to uncertainties around the economic outlook, but "it may soon be appropriate for policy to act to address the growing risks of persistently elevated inflation." Hammack spoke Tuesday at an event in Cleveland.

Castor Maritime (NASDAQ:CTRM) reported a significant turnaround in its financial performance for the first quarter of 2026, driven by steady operational growth and substantial non-operating gains from its investment holdings.

President Donald Trump said he is tapping Bill Pulte, the head of the Federal Housing Finance Agency, as the acting Director of National Intelligence. Pulte will keep running the FHFA as well. Bloomberg's Tyler Kendall reports.

Legend Biotech (NASDAQ:LEGN) announced encouraging initial clinical data from an ongoing Phase 1 study evaluating LB2501, its experimental in vivo CD19/CD20 dual-targeting CAR-T therapy, for the treatment of patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

The Buckle (NYSE:BKE) announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per share, sustaining the retail company's program of regular distributions to its public investors.

Voyager Technologies (NYSE:VOYG) has signed a definitive agreement to acquire Astrobotic Technology, a privately held developer of commercial lunar delivery systems, surface power infrastructure, and reusable rockets.

Vera Therapeutics (NASDAQ:VERA) has reached an agreement with the U.S. Food and Drug Administration to accelerate the regulatory timeline for its experimental kidney disease treatment, clearing the path for an earlier analysis of pivotal Phase 3 data.

BeyondSpring (NASDAQ:BYSI) announced updated data from an investigator-initiated Phase 2 clinical trial evaluating a triple-combination therapy for patients with advanced lung cancer, demonstrating sustained overall survival and disease control in a difficult-to-treat population.